Yanying He

IDO as a drug target for cancer immunotherapy: recent developments in IDO inhibitors discovery

Shan Qian, Man Zhang, Quanlong Chen et al. · RSC Advances · 2016 · 59 citations

Recent Advances, Drug Target, Chemical Structures +14

Discovery of 2-((4,6-dimethylpyrimidin-2-yl)thio)- N -phenylacetamide derivatives as new potent and selective human sirtuin 2 inhibitors

Lingling Yang, Xiaobo Ma, Yuan Chen et al. · European Journal of Medicinal Chemistry · 2017 · 48 citations · Full text

Medicinal Chemistry, Biochemistry, Medicine +11

Discovery and preliminary structure–activity relationship of 1H-indazoles with promising indoleamine-2,3-dioxygenase 1 (IDO1) inhibition properties

Shan Qian, Tao He, Wei Wang et al. · Bioorganic & Medicinal Chemistry · 2016 · 39 citations · Full text

Medicinal Chemistry, Biochemistry, Inhibition Properties +8

Design and Synthesis of New 9‐Substituted Norharmane Derivatives as Potential Sirt5 Inhibitors

Lingling Yang, Yanying He, Quanlong Chen et al. · Journal of Heterocyclic Chemistry · 2016 · 14 citations

Drug Target, Peptide Science, Potential Sirt5 Inhibitors +18

BmPGPR‐L4 is a negative regulator of the humoral immune response in the silkworm <i>Bombyx mori</i>

Weiyi Yang, Yongyi Lin, Yanying He et al. · Archives of Insect Biochemistry and Physiology · 2024 · 11 citations